Event promotes introduction of new technology, innovation, deliberates on various issues related to dissolution
Society for Pharmaceutical Dissolution Science (SPDS) recently conducted its 3rd Annual International Convention Disso India 2015 in Goa. The event aimed to promote introduction of new technology, innovation. The event also saw deliberations on various issues related to dissolution. It saw the presence of eminent professionals from the pharma industry.
The event was organised under the chairmanship of Salim A Veljee, Director – Food and Drugs Administration, Goa and the Organising Secretary, Anant Naik, Deputy General Manager-Quality, Unichem Laboratories, Goa. The scientific sessions were programmed and executed under the chairmanship of Dr Mangal Nagarsenker, HOD and Professor of Pharmaceutics, Bombay College of Pharmacy, Mumbai.
The event comprised plenary lectures, panel discussion and exhibits. Around 150 delegates participated in this mega symposium focussing on dissolution. Dr Prakash Amrut Mody, Chairman and Managing Director, Unichem Laboratories was the Chief Guest of the symposium. Salim Velji, Chairman of the symposium released the scientific abstract book during the inauguration.
Dr Vinod P Shah, Ex US FDA, Pharmaceutical Consultant, US spoke on dissolution data in new and generic drug regulatory submissions: USFDA Perspective; Dr Suresh Venkatram, Chief Scientific Officer, Semler Research, Bengaluru, India spoke on bio-relevant and discriminating dissolution test methods, Samir Haddouchi, Managing Director, SPS Pharma Services, Clermont Ferrand, France elaborated on dissolution studies for novel drug delivery systems, Dr A Atilla Hincal, Founder and General Manager, IDE Pharmaceutical Registration Biopharmaceutics Consultancy, Ankara, Turkey gave insights on regulatory aspects related to dissolution studies: European perspective, Dr Nevin Çelebi, Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Turkey spoke on fed and fasted condition dissolution studies, Vijay Kshirsagar, Director and CEO, TRAC Pharma Consulting, Mumbai elucidated on Qbd approach in dissolution studies, Vatsala Naageshwaran, Director of Operations, Absorption Systems, US talked on advancing methods for equivalence of ophthalmic and topical drug products – A new vision for the future, Prof Imre Klebovich, Semmelweis University Department of Pharmaceutics, Budapest, Hungary spoke on predicting drug interactions from dissolution studies, Dr Sandip Tiwari, Actavis Laboratories FL, Florida, US informed on recent innovations in dissolution testing, Dr Constantin Mircioiu, President, Pharmaceutical Dept. Academy of Medical Sciences, Bucharest, Romania discussed on statistical sampling and dissolution data analysis, Makarand Avachat, Sr Vice President, R&D – Formulations, Lupin Laboratories gave insights on linking CQA and CPP to clinically relevant dissolution method, and Umesh Banakar, Professor and President, Banakar Consulting Services, US talked on beyond guidances: Convincing regulatory authorities of data interpretation and data integrity.
During the event, a deskbook of pharmaceutical dissolution science and applications was also released at the hands of Mody.
Comments are closed.